Vista Pharmaceuticals rallies 5% as firm submits ANDA for cardiac drug to USFDA

The pharma company informed exchanges that it has submitted abbreviated new drug application (ANDA) to US Foods and Drugs Administration, on September 25, for a cardiac drug.

September 26, 2017 / 15:10 IST

Granules India Ltd.

26 Aug, 2025 12:21

Volume

Todays L/H

Vista Pharmaceuticals share price rallied nearly 5 percent intraday Tuesday to hit a fresh 52-week high of Rs 52.60 on submission of ANDA to the US health regulator.

The pharma company informed exchanges that it has submitted abbreviated new drug application (ANDA) to US Foods and Drugs Administration, on September 25, for a cardiac drug.

The company has been partnered with the US company for this project.

At 14:57 hours IST, the stock price was quoting at Rs 51.50, up Rs 1.40, or 2.79 percent on the BSE.

first published: Sep 26, 2017 03:10 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347